Corbus Pharmaceuticals Holdings (CRBP) Balance Sheet: Assets & Liabilities

Corbus Pharmaceuticals Holdings (CRBP) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Corbus Pharmaceuticals Holdings reported total assets of $168.19M and total liabilities of $20.69M. Shareholders' equity was $147.50M, up 3.6% from $142.43M a year earlier. Total debt stood at $1.63M against $163.94M in cash and short-term investments, a net cash position of $162.31M. That puts debt-to-equity at 0.01, compared with 0.03 a year earlier.

Corbus Pharmaceuticals Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Corbus Pharmaceuticals Holdings, Inc. (CRBP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	28.49	17.20	13.72	17.00	25.01	85.43	31.75	41.75	62.54
Short-Term Investments	134.78	131.86	7.18	42.19	72.64	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	163.94	149.06	20.91	59.20	97.65	85.43	31.75	41.75	62.54
Accounts Receivable	1.50	0.00	0.00	0.00	0.00	2.58	2.68	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.35	-2.68	0.00	0.00
Other Current Assets	1.52	3.63	2.64	0.98	2.56	3.71	6.41	4.98	2.97
Total Current Assets	166.95	152.98	23.55	60.18	100.20	92.07	38.15	44.24	65.50
Non-Current Assets
Property, Plant & Equipment (Net)	1.24	2.52	4.04	5.50	7.00	9.32	10.90	2.71	1.43
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.67	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.39	0.69	0.63	0.52	0.23	0.08	0.04	0.04
Total Non-Current Assets	1.24	2.90	4.73	6.13	7.53	10.22	10.99	2.75	1.47
Total Assets	168.20	155.88	28.27	66.31	107.73	102.29	49.14	46.99	66.98
Current Liabilities
Accounts Payable	2.22	4.79	3.18	2.17	1.78	7.38	11.09	6.35	3.13
Short-Term Debt	1.63	3.21	17.65	4.43	5.00	1.71	1.35	0.39	0.33
Current Portion of Long-Term Debt	-	-	16.21	2.80	3.09	0.71	-	-	-
Accrued Liabilities	13.99	3.15	11.03	6.00	7.38	22.01	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.46	0.00
Other Current Liabilities	16.84	3.82	11.07	6.04	10.23	22.80	22.45	9.89	4.74
Total Current Liabilities	20.69	11.82	31.89	12.64	17.01	31.90	34.89	18.09	8.20
Non-Current Liabilities
Long-Term Debt	0.00	1.63	3.24	20.66	21.59	25.12	8.10	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.04	0.02	0.02	0.00	0.00	1.38	0.99
Total Non-Current Liabilities	0.00	1.63	3.28	20.68	21.61	25.12	8.10	1.38	0.99
Total Liabilities	20.69	13.45	35.18	33.32	38.62	57.02	42.98	19.47	9.19
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-555.43	-476.89	-436.68	-392.08	-349.73	-304.09	-192.82	-121.37	-65.70
Accumulated Other Comprehensive Income	-0.05	0.04	0.00	-0.13	-0.06	0.00	0.00	-0.67	-0.36
Additional Paid-in Capital	702.98	619.29	429.78	425.20	418.89	349.36	198.98	148.89	123.48
Shares Outstanding	17.61	12.18	4.42	4.17	4.17	-	-	-	-
Total Stockholders' Equity	147.50	142.43	-6.91	32.99	69.11	45.27	6.16	27.52	57.78
Total Liabilities & Equity	168.20	155.88	28.27	66.31	107.73	102.29	49.14	46.99	66.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Corbus Pharmaceuticals Holdings Balance Sheet

How much debt does Corbus Pharmaceuticals Holdings have?

Corbus Pharmaceuticals Holdings had total debt of $1.63M as of Dec 31, 2025, against $163.94M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $4.84M a year earlier.

What are Corbus Pharmaceuticals Holdings's total assets?

Corbus Pharmaceuticals Holdings reported total assets of $168.19M as of Dec 31, 2025, up 7.9% from $155.88M a year earlier. Total liabilities were $20.69M.

What is Corbus Pharmaceuticals Holdings's shareholders' equity?

Corbus Pharmaceuticals Holdings's shareholders' equity was $147.50M as of Dec 31, 2025, or about $8.38 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition